[Monitoring of the harmful effects of iron on the hearts of patients with beta-thalassemia major, using non-invasive cardiological technics].
D000293:Adolescent; D000328:Adult; D009202:Cardiomyopathies / Q000139:chemically induced*; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000009:adverse effects; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D007223:Infant; D007502:Iron Chelating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D013789:Thalassemia / Q000188:drug therapy*; D014672:Vectorcardiography
D007502:Iron Chelating Agents; D003676:Deferoxamine
Monitoraggio degli effetti dannosi del ferro nel cuore dei pazienti con beta-thalassemia major con tecniche cardiologiche non invasive.